⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SLN News
Silence Therapeutics Plc American Depository Share
Halper Sadeh LLC is Investigating Whether BWMN, HZO, SLN are Obtaining Fair Deals for their Shareholders
globenewswire.com
BWMN
HZO
SLN
Polycythemia Vera - Global Drug Pipeline Insight, 2026 | 25+ Therapies Drive JAK2-Targeted Innovation and Late-Stage Partnership Opportunities
globenewswire.com
INCY
MRK
PRLD
SLN
Silence Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silence Therapeutics plc - SLN
businesswire.com
SLN
Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders?
prnewswire.com
BRZE
RXO
SLN
OPCH
A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday
prnewswire.com
AGIO
KROS
PTGX
IRON
SLN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)
globenewswire.com
SLN
OPCH
RXO
SANG
MCK
CHRW
Form 8-K
sec.gov
SLN
SLNCF
RNA Interference Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, and Silence Therapeutics
globenewswire.com
ALNY
ARWR
SLN
BNTC
RNA Therapeutics Market Size, Share & Trends Analysis - Global Forecast to 2036
globenewswire.com
MRNA
BNTX
CVAC
ALNY
IONS
ARWR
REGN
SRPT
SLN
BEAM
NTLA
CRSP
2026 RNAi Therapeutics Market Report (3rd Edition): Analysis by Type of RNAi Molecule, Therapeutic Area, Route of Administration, Key Geographical Regions, Sales Forecast and Leading Industry Players to 2035
globenewswire.com
ALNY
ARWR
NVO
NVS
BIIB
REGN
GILD
MRK
BMY
ABBV
AMGN
AZN
PFE
SNY
TEVA
BHC
CRSP
EDIT
NTLA
SRPT
SLN